In the competitive biotech landscape, groundbreaking science alone isn’t enough. As highlighted in a recent article by Dynamic Business, Cartherics’ strategic appointment of U.S. biotech executive Laurence Nore underscores the critical importance of navigating the complexity of healthcare markets. Laurence emphasises that many promising biotech firms falter not due to flawed science but because they fail to navigate the complex healthcare market dynamics.

Understanding the multifaceted healthcare ecosystem, including prescribers, payers, and patients is essential. Cartherics is committed to bridging this gap by developing cell therapies that not only offer innovative treatments but also address the real-world challenges patients face.

At Cartherics, we recognise that to make a meaningful impact, we must communicate our science effectively and build trust with stakeholders. Read the article in Dynamic Business here: https://dynamicbusiness.com/featured/the-marketing-reality-check-why-great-science-isnt-enough.html